Visual Performance With a Hydrophobic Aspheric Monofocal IOL
NCT ID: NCT03819582
Last Updated: 2019-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2018-02-01
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Aspheric Intraocular Lenses for Micro-monovision
NCT05531110
Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
NCT05506553
Assessment of Visual Function and Optics in Intraocular Lenses
NCT01654159
Visual Function of Enhanced Monofocal Intraocular Lenses
NCT07262021
Study on Visual Performance of a Monofocal Intraocular Lens
NCT04740788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each subject will be evaluated at two visits following IOL implantation; visit 1 (1 month post implantation), Visit 2 (3 months post implantation).
At both post-operative visits the patient will undergo:
Refraction Uncorrected and best corrected distance and near visual acuity measurement Optical biometry to assess ELP Slit lamp biomicroscopy to assess for post-operative complications
At the time of surgery, the ophthalmic surgeon will complete a questionnaire, detailing lens insertion time and ease of use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraocular lens
Subjects implanted with the EyeCee One Intraocular lens
EyeCee One intraocular lens
Hydrophobic aspheric monofocal intraocular lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EyeCee One intraocular lens
Hydrophobic aspheric monofocal intraocular lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Corneal astigmatism of \>1.00D
* Dilated pupil size smaller than 5mm
* Macular pathology
* Glaucoma
* Retinal disease
* Corneal disease
* Abnormal iris
* Pupil deformation
* Any previous corneal or intraocular surgery
* Any patient who had surgical complications will also be excluded from participation in the study.
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Plymouth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Phillip J Buckhurst
Associate Head of School for Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BMI Southend Hospital
Westcliff-on-Sea, Essex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/WM/0181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.